RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 98 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,731,776 | +110.4% | 337,264 | +63.7% | 0.00% | +50.0% |
| Q2 2023 | $3,675,664 | 0.0% | 206,035 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $3,675,664 | +199.1% | 206,035 | +388.3% | 0.00% | +100.0% |
| Q4 2022 | $1,228,777 | -99.8% | 42,197 | +41.0% | 0.00% | – |
| Q3 2022 | $733,459,000 | +222.4% | 29,937 | -45.4% | 0.00% | – |
| Q2 2022 | $227,515,000 | -32.9% | 54,823 | +86.3% | 0.00% | – |
| Q1 2022 | $339,045,000 | +15.4% | 29,431 | 0.0% | 0.00% | – |
| Q4 2021 | $293,722,000 | -10.8% | 29,431 | +16.7% | 0.00% | – |
| Q3 2021 | $329,309,000 | -33.3% | 25,215 | 0.0% | 0.00% | – |
| Q2 2021 | $493,709,000 | +121.1% | 25,215 | +140.2% | 0.00% | – |
| Q1 2021 | $223,250,000 | -74.2% | 10,496 | -64.0% | 0.00% | – |
| Q4 2020 | $865,916,000 | +25.0% | 29,126 | -8.9% | 0.00% | – |
| Q3 2020 | $692,660,000 | +62.9% | 31,964 | +67.7% | 0.00% | – |
| Q2 2020 | $425,104,000 | – | 19,063 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 909,258 | $10,475,000 | 3.58% |
| NEA Management Company, LLC | 4,912,306 | $56,590,000 | 1.64% |
| RA Capital Management | 4,871,067 | $56,115,000 | 1.22% |
| Pinz Capital Management, LP | 148,475 | $1,710,000 | 1.07% |
| Samsara BioCapital, LLC | 345,293 | $3,978,000 | 1.00% |
| Bell & Brown Wealth Advisors, LLC | 117,400 | $1,352,000 | 0.61% |
| Rock Springs Capital Management LP | 1,237,026 | $14,251,000 | 0.36% |
| ACT CAPITAL MANAGEMENT, LLC | 27,500 | $317,000 | 0.34% |
| Endurant Capital Management LP | 105,792 | $1,219,000 | 0.32% |
| Baker Brothers Advisors | 4,125,062 | $47,521,000 | 0.27% |